Author: KOTWAL Abhishek
Learn about a study comparing intra-arterial Nimodipine and intra-venous Milrinone for the management of delayed cerebral ischemia in this presentation from Dr. Abhishek Kotwal (Neuroradiology, NIMHANS, India).
CASE PRESENTATION
METHODS
IAN PROTOCOL
IVM PROTOCOL
OUTCOMES AT THE END OF THERAPY
RESULTS
GCS AT PRESENTATION
MOTOR RESPONSE AT PRESENTATION
Patients in IVM group(vs IAN group) had poorer motor response[<M6 response,5/13(38.4%)vs5/21(23.8%),p=0.36]
MODIFIED FISHER GRADES OF SAH AT PRESENTATION
Patients in IVM group(vs IAN group) had higher grades [modified Fisher ≥3) of SAH {12/13(92.3%)vs8/21(85.7%),p=0.56}].
CLINICAL IMPROVEMENT
After the end of the therapy, more patients in the IAN group(vs IVM group) showed clinical improvement [17/21(80.9%)vs10/13(76.9%),p=0.77].
DEVELOPMENT OF NEW INFARCTS
After the end of the therapy, more patients in the IAN group(vs IVM group) showed the development of new infarcts[15/21(71.4%)vs7/13(53.8%),p=0.29] on the last CT/MRI.
DISCHARGED TO HOME
After the end of the therapy, more patients in the IAN group(vs IVM group) were discharged to home[13/21(61.9%)vs6/13(46.1%),p=0.36]
MORTALITIES AT DISCHARGE
After the end of the therapy, patients in IAN group(vs IVM group) had less mortalities[2/21(9.5%)vs3/13(23.0%),p=0.027].
LIMITATIONS
CONCLUSION
Endovascular Treatment of Isolated Transverse Sinus Dural-AV Fistula
Natural course of extensive intimal hyperplasia after aneurysm-treatment with a flowdiverter